Tebentafusp
- Generic Name
- Tebentafusp
- Brand Names
- Kimmtrak
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1874157-95-5
- Unique Ingredient Identifier
- N658GY6L3E
- Background
Tebentafusp is a gp100 peptide-HLA-directed CD3 T cell engager. It is a bispecific, fusion protein and first-in-class drug of immune-mobilizing monoclonal T cell receptors against cancer (ImmTACs), a recently developed cancer immunotherapy with a novel mechanism of action. ImmTACs bind to target cancer cells that express a specific antigen of interest and re...
- Indication
Tebentafusp is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
- Associated Conditions
- Metastatic Uveal Melanoma, Unresectable Uveal Melanoma
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath